Picture of Camellia logo

CAM Camellia News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesBalancedSmall CapSuper Stock

Director/PDMR Shareholding

RNS Number : 4657Y

Camellia PLC

08 September 2025

 

Camellia Plc

PDMR Dealing Announcement

 

8 September 2025

Camellia plc (the "Company") announces that the following transaction in the Company's ordinary shares of 10p each ("Shares") has been undertaken by directors/persons discharging managerial responsibility ("PDMR").

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail in respect of the transactions described above.

1Details of the person discharging managerial responsibilities/person closely associated
a)Name:Alec Hayley
2Reason for the notification
a)Position/status:PDMR / Non-Executive Director
b)Initial notification/Amendment:Initial Notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)Name:Camellia Plc
b)LEI:213800QKY5L2AC1NFX23
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument:
Identification code:
Ordinary 10p shares
GB0001667087
b)Nature of the transaction:Purchase
c)Price(s) and volume(s):PriceVolume
£57.94100
£58.0072
d)Aggregated information:PriceAggregated Volume
£9970.00172
e)Date of the transaction:8 September 2025
f)Place of the transaction:LSE / XLON
ENQUIRIES 
Camellia Plc01622 746655
Byron Coombs Chief Executive Officer
Oliver Capon, Chief Financial Officer
Panmure Liberum020 7886 2500
Nominated Adviser and Broker
Emma Earl
William Goode
Rupert Dearden
H/Advisers Maitland
PR
William Clutterbuck07785 292617
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     DSHUPUAWBUPAGAR

Recent news on Camellia

See all news